Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind double-dummy trial of 复方ACC007片 for maintenance treatment of HIV-1 infection
CTR20212312Phase 3Completed
- Sponsor
- Aidi Pharmaceutical
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ainuovirine + lamivudine + tenofovir disoproxil fumarate in Human immunodeficiency virus infection type 1, sponsored by Aidi Pharmaceutical. Started Nov 2021; status: completed.
02
Drugs
ainuovirine + lamivudine + tenofovir disoproxil fumarate
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on CTR20212312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212312.